Yu Cui, Ruihua Mi, Lin Chen, Lin Wang, Dongbei Li, Xudong Wei. Case report: Venetoclax plus Azacitidine in treatment of acute undifferentiated leukemia.Hematology (Amsterdam, Netherlands). 2024, 29 (1): 2293494
Wenke Wu, Lei Miao, Lidong Zhao, Yuanxin Zhu, Jianping Mao, Zhimei Cai, Yajun Ji, Lei Wang, Ying Wang, Tao Jia. Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma.Hematology (Amsterdam, Netherlands). 2024, 29 (1): 2293514
Abdullah AlZahrani, Nada Alsuhebany, Imran K Tailor, Abdullah M Alrajhi. Advancing the understanding of venetoclax in t(11;14)-positive multiple myeloma: a comprehensive review of clinical evidence and future prospects.Hematology (Amsterdam, Netherlands). 2024, 29 (1): 2296809
Tabea Sutter, Marcus Schittenhelm, Thomas Volken, Thomas Lehmann. Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis.Hematology (Amsterdam, Netherlands). 2023, 28 (1): 2206694
Olga Benítez-Hidalgo, Marc Bosch Schips, Juan Carlos Juárez Giménez, Mercedes Gironella. Benefits of rIX-FP prophylaxis in patients with Haemophilia B: real-world evidence from a Spanish reference centre.Hematology (Amsterdam, Netherlands). 2023, 28 (1): 2242656
Chunli Wang, Guoqing Liu, Yaguang Ding, Zekun Li, Yingzi Zhen, Jie Cui, Wanru Yao, Ai Di, Kun Huang, Ping Feng, Runhui Wu. Application of peripherally inserted central catheter in immune tolerance induction treatment of children with hemophilia A and accompanying inhibitors in China.Hematology (Amsterdam, Netherlands). 2023, 28 (1): 2250601
Jiaheng Guan, Jinlong Ma, Baoan Chen. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.Hematology (Amsterdam, Netherlands). 2023, 28 (1): 2254556